Valerio-Ureña Joaquín, Vásquez-Fernández Francisco, Pérez-Sosa Julio A, Cortazar-Benitez Luis F, Chávez-Tapia Norberto C, Ruvalcaba-Rojas Oscar A, Torres-Medina Verónica, Ocejo-Rodríguez Agustín
Facultad de Medicina Miguel Alemán Valdés, Universidad Veracruzana, Veracruz, Veracruz, México.
Gac Med Mex. 2009 May-Jun;145(3):183-7.
Chronic liver disease has a high mortality among the Mexican population. However epidemiological data on hepatitis B (HBV) and hepatitis C (HCV) infection in the southeast areas of the country is limited. Our objective was to report the prevalence of blood markers of HBV and HCV among blood donors from the capital city of Veracruz, Mexico.
Between January and December 2005 we analyzed the results of the screening tests used to detect serological markers of HBV and HCV infection (HBsAg and anti-HCV). We included demographic data of blood donors from the State Center for Blood Transfusion of the capital city of Veracruz.
We reviewed 8,650 blood donor reports and found a prevalence of 0.057% and 1.1% for AgsHB and anti-HCV respectively. Only 2.97% of all individuals with a positive test had been previously screened for hepatic viruses.
Results from our study indicate that the central and southeast regions of the state of Veracruz have a high anti-HCV prevalence among blood donors when compared with results from other states in Mexico. Further studies should evaluate risk factors in regions with high HCV seropositivity.
慢性肝病在墨西哥人群中具有较高的死亡率。然而,该国东南部地区乙型肝炎(HBV)和丙型肝炎(HCV)感染的流行病学数据有限。我们的目的是报告墨西哥韦拉克鲁斯州首府献血者中HBV和HCV血液标志物的流行情况。
在2005年1月至12月期间,我们分析了用于检测HBV和HCV感染血清学标志物(HBsAg和抗-HCV)的筛查测试结果。我们纳入了韦拉克鲁斯州首府输血中心献血者的人口统计学数据。
我们审查了8650份献血者报告,发现HBsAg和抗-HCV的流行率分别为0.057%和1.1%。所有检测呈阳性的个体中,只有2.97%曾接受过肝脏病毒筛查。
我们的研究结果表明,与墨西哥其他州的结果相比,韦拉克鲁斯州中部和东南部地区献血者中的抗-HCV流行率较高。进一步的研究应评估HCV血清阳性率高的地区的危险因素。